Logo Sociedade Brasileira de Coluna
Buy Now
Home›The Treatise›Chapters›Chapter 42
Tratado de Cirurgia da Coluna Vertebral
SECTION 5 • Degenerative Diseases
Chapter42

Pathophysiology of Intervertebral Disc Degeneration

Authors:Asdrubal Falavigna•Enzo Pasetto Righesso•Maria Eduarda Lima Viapiana•Orlando Righesso Neto•Vincenzo Fin Falavigna
Vancouver: Righesso Neto O, Falavigna A, Falavigna VF, Viapiana MEL, Righesso EP📖 Pages: 569-578
Full reading of this chapter is available exclusively in the printed edition of the Treatise.
Where to Buy🛒View references📖Treatise in Debate▶
Sec. 5Degenerative Diseases
Cap. 42Clinical Chapter
5authors
Português
Español
English
Referênciasscientific citations
📑

Chapter Summary

• Context: Intervertebral disc degeneration (IDD) is a complex multifactorial process wherein physiological aging, genetic predisposition, mechanical loading, systemic metabolism, lifestyle factors, and chronic inflammation progressively interact. Although some disc changes are part of normal physiological senescence, pathological disc degeneration involves loss of cellular homeostasis, extracellular matrix degradation, proteoglycan depletion, dehydration, persistent pro-inflammatory cytokine cascades, and progressive biomechanical failure. As an essentially avascular organ relying on nutrient diffusion across cartilaginous endplates, the disc is uniquely vulnerable to metabolic and mechanical insults. Degenerative MRI changes are also prevalent in asymptomatic individuals, making it vital to avoid automatic conflation of imaging findings with clinical pain. The chapter expands beyond traditional purely mechanical models to explore cellular senescence and programmed cell death, genetics and epigenetics, metabolic syndrome, oxidative stress, immune cell infiltration, neoangiogenesis, neurogenesis, and the emerging role of lifestyle modifications and regenerative biological therapies.
• Chapter Objective: To elucidate the fundamental biological and biomechanical mechanisms driving intervertebral disc degeneration, identify associated genetic, environmental, and metabolic risk factors, understand extracellular matrix alterations and correlate them with MRI grading systems (Pfirrmann, Modic), explore modifiable lifestyle factors, and critically evaluate emerging cellular, biomaterial, and molecular regenerative strategies.
• The disc as an integrated biological and mechanical unitThe nucleus pulposus, annulus fibrosus, and cartilaginous endplates function as a synchronized unit for mechanical load distribution (Figure 42.1). High hydration and aggrecan content allow the nucleus to resist compressive loads via hydrostatic pressure, which the lamellar annulus contains radially, while endplates mediate nutrient diffusion and waste clearance.
• Aging is not synonymous with pathological degenerationThe chapter distinguishes physiological senescence from pathological degeneration. In the latter, accelerated cell death, senescence-associated secretory phenotypes (SASP), oxidative stress, and matrix metalloproteinases (MMPs/ADAMTS) tip the balance toward extracellular matrix breakdown, loss of type II collagen and aggrecan, dehydration, and structural cleft formation.
• Genetics, epigenetics, and systemic metabolismGenetic predisposition strongly influences individual susceptibility, mediated by polymorphisms in matrix genes (COL9A2, ACAN) and cytokine cascades (IL-1, TNF-alpha). Epigenetic mechanisms, including DNA methylation and microRNAs, regulate disc cell longevity. Concurrently, obesity, diabetes mellitus, insulin resistance, and advanced glycation end-products (AGEs) disrupt the disc microenvironment through microvascular impairment, oxidative stress, and chronic low-grade inflammation.
• Inflammation, neovascularization, and discogenic painWith annular tears and structural breakdown, pro-inflammatory cytokines stimulate ingrowth of capillary vessels (VEGF) and unmyelinated nociceptive nerve fibers (NGF) into deep, normally aneural disc regions. This neurovascular ingrowth directly links structural matrix breakdown and inflammatory signaling with discogenic pain, without implying that every degenerated disc is symptomatic.
• Imaging and radiological classificationsThe Pfirrmann and Modic classifications (Figures 42.2 and 42.3) organize distinct aspects of disc pathology: Pfirrmann grades disc height loss, signal intensity, and nucleus-annulus distinction, while Modic classifies subchondral bone marrow edema, fatty marrow conversion, and sclerosis in vertebral endplates.
• Prevention and emerging regenerative therapiesPhysical exercise, smoking cessation, and metabolic control are discussed as modifiable factors supporting disc health. Emerging regenerative strategies—mesenchymal stem cells, injectable hydrogel biomaterials, gene therapy, and epigenetic modulation—represent promising frontiers, although the authors caution against premature clinical extrapolation before robust randomized trials demonstrate long-term efficacy.
• Clinical Application: In clinical practice, the primary application is avoiding the automatic assumption that disc degeneration on MRI is the clinical pain generator. Structural disc changes and Modic signals are common in asymptomatic populations and must be correlated with history, physical exam, and specific provocative findings. Simultaneously, recognizing disc degeneration as a systemic biological disease broadens management: controlling diabetes, obesity, smoking, and physical inactivity protects spinal health. Pfirrmann and Modic grading standardize communication, but do not replace clinical judgment. Finally, clinicians must critically appraise marketed regenerative therapies (stem cell injections, biologics, supplements), ensuring patients understand the distinction between experimental biological research and validated clinical treatments.
🏷️

Keywords

Preferred DeCS/MeSH Descriptors:
Intervertebral Disc DegenerationIntervertebral DiscLow Back PainInflammationOxidative StressExtracellular MatrixMagnetic Resonance ImagingRegenerative Medicine
⭐

Why this chapter matters

Most degenerative spinal pathologies—herniations, stenosis, instability, adult scoliosis—originate from or relate to disc degeneration. Understanding what occurs at the cellular and biochemical level before structural collapse transforms how clinicians evaluate imaging, counsel patients, and approach future treatments that aim not merely to resect or fuse degenerate structures, but to modify the biological cascade of disease.

“Intervertebral disc degeneration results from the intricate interaction of aging, genetics, biomechanical stress, systemic metabolism, chronic inflammation, and lifestyle. It is neither simple mechanical 'wear and tear' nor an automatic explanation for low back pain. Understanding its biological foundation enables accurate imaging interpretation, identification of modifiable risk factors, and rigorous appraisal of novel regenerative and molecular interventions.”
✨

Chapter Highlights

🌐
Card 1 — Core Concept
More Than Mechanical Wear and Tear

Disc degeneration involves loss of cellular homeostasis, catabolic enzyme upregulation, matrix degradation, and metabolic disruption. Aging participates in the process, but cannot independently explain why specific discs degenerate prematurely or become painful.

🩺
Card 2 — Clinical Decision
Imaging Does Not Equal Clinical Pain

Degenerative disc changes and Modic signals are highly prevalent in asymptomatic individuals. Pfirrmann and Modic grading systems organize imaging findings, but never replace clinical correlation with patient symptoms and physical examination.

📐
Card 3 — Pearl / Alert
Regenerative Therapies Require Scientific Caution

Stem cell therapies, injectable biomaterials, and gene modulation represent promising frontiers. However, they remain in various stages of experimental investigation and should not be prematurely marketed as established clinical cures.

📑

How to Cite this Chapter (Vancouver Format)

Official bibliographic indexing and citation guidelines
📖 Pages: 569-578Vancouver Style
Authors (Vancouver):Righesso Neto O, Falavigna A, Falavigna VF, Viapiana MEL, Righesso EP

Righesso Neto O, Falavigna A, Falavigna VF, Viapiana MEL, Righesso EP. Fisiopatologia da degeneração discal. In: Pudles E, Defino H, Risso M, editors. Tratado de Cirurgia da Coluna Vertebral (Treatise of Spine Surgery). 1st ed. Rio de Janeiro: Dilivros Editora; 2026. p. 569-578.

ISBN: 978-85-8053-292-0 • 1.ª Edição • Dilivros Editora
📚

Bibliographic References

1. Modic MT, Ross JS. Lumbar degenerative disk disease. Radiology. 2007;245(1):43-61.
2. Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-67.
3. Wang F, et al. Aging and degenerative changes of intervertebral disc. Int J Mol Sci. 2016;17(8):1324.
4. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine. 2006;31(18):2151-61.
5. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine. 1995;20(11):1307-14.
6. Vo NV, Hartman RA, Patil PR, Risbud MV, Kletsas D, Iatridis JC, et al. Molecular mechanisms of biological aging in intervertebral discs. J Orthop Res. 2016;34(8):1289-306.
7. Eskola PJ, et al. Genetic risk factors in symptomatic lumbar disc disease. Spine. 2010;35(11):1234-238.
8. Hangai M, et al. Age-related changes in the lumbar intervertebral discs and their association with low back pain: a large-scale population-based study. Osteoarthritis Cartilage. 2008;16(8):994-1000.
9. Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44-56.
10. Videman T, et al. The relative roles of inheritance and physical load in degenerative changes of the lumbar spine. Spine. 2005;30(6):697-703.
11. Sowa GA, et al. Epigenetic changes in intervertebral disc disease. Front Cell Dev Biol. 2020;8:580186.
12. Samartzis D, et al. The biology of disc degeneration: genetics and beyond. J Orthop Res. 2015;33(9):1333-45.
13. Urban JPG, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5(3):120-30.
14. Raj PP. Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Pract. 2008;8(1):18-44.
15. Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG. The molecular basis of intervertebral disc degeneration. Spine J. 2013;13(3):318-30.
16. Wang DL, et al. The effects of static load on intervertebral disc degeneration in a rat tail model. Spine. 2007;32(23):E667-E673.
17. Fields AJ, et al. Role of metabolic syndrome and its components in the development of spine disease. J Bone Joint Surg Am. 2015;97(10):760-68.
18. Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368-83.
19. Gruber HE, et al. Apoptosis in intervertebral disc degeneration. Spine J. 2002;2(4):252-260.
20. Wang F, et al. Inflammation and oxidative stress in intervertebral disc degeneration: molecular insights and therapeutic targets. J Orthop Translat. 2020;24:83-93.
21. Kim H, et al. Programmed necrosis, not apoptosis, is responsible for the cell death in disc degeneration. J Orthop Res. 2021;39(1):86-96.
22. Sambrook PN, MacGregor J, Spector TD. Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis Rheum. 1999;42(2):366-72.
23. Solovieva S, et al. IL1 gene cluster polymorphisms and intervertebral disc degeneration: results from a Finnish population sample. J Med Genet. 2004;41(2):e21.
24. Videman T, et al. The association of VDR and COL9A2 gene polymorphisms with lumbar disc degeneration. Spine. 2001;26(23):2487-91.
25. Liu ZH, et al. DNA methylation status of the ACAN gene promoter influences the degeneration of human intervertebral disc. PLoS One. 2014;9(1):e85766.
26. Song YQ, et al. The role of microRNAs in intervertebral disc degeneration. Orthop Surg. 2020;12(2):445-54.
27. Song YQ, et al. MicroRNA-155 regulates inflammatory responses in nucleus pulposus cells by targeting TCF4. Spine. 2021;46(1):E21-E29.
28. Song YQ, et al. Nanoparticle-mediated delivery of miR-199a inhibits degeneration of intervertebral discs in rats. Biomaterials. 2020;245:119978.
29. Song YQ, et al. miR-21 promotes matrix degradation in intervertebral disc degeneration by targeting PTEN. J Orthop Res. 2019;37(6):1263-73.
30. Gruber HE, et al. Increased cell senescence is associated with decreased cell proliferation in vivo in the degenerating human annulus. Spine J. 2010;10(10):849-56.
31. Fang F, et al. Oxidative stress and intervertebral disc degeneration: evidence from antioxidant therapies. Oxid Med Cell Longev. 2022;2022:6694380.
32. Le Maitre CL, et al. Altered gene expression in human nucleus pulposus cells isolated from degenerate intervertebral disc. Spine. 2007;32(17):1744-51.
33. Wang J, et al. Inflammatory cytokines induce ADAMTS-5 and MMP expression in human intervertebral disc cells. J Orthop Res. 2014;32(6):965-72.
34. Illien-Jünger S, et al. Diabetes mellitus increases susceptibility to intervertebral disc degeneration by oxidative stress, inflammation, and accelerated cell senescence. Spine. 2013;38(14):E869-E881.
35. Binch AL, et al. Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Spine. 2015;40(9):593-600.
36. Zhang W, et al. Anti-inflammatory and antioxidant effects of resveratrol on intervertebral disc degeneration: in vitro and in vivo studies. Cell Physiol Biochem. 2018;47(2):849-63.
37. Yang SH, et al. Curcumin attenuates matrix degradation via the inhibition of the NF-κB pathway in interleukin-1β-induced human nucleus pulposus cells. Int J Mol Med. 2018;42(2):755-764.
38. Iatridis JC, et al. Degeneration of the intervertebral disc with aging. Orthop Clin North Am. 2011;42(4):561-71.
39. Le Maitre CL, et al. Expression of matrix metalloproteinases and their inhibitors in the human intervertebral disc: implications for disc degeneration. Arthritis Res Ther. 2007;9(3):R83.
40. Antoniou J, et al. The role of cytokines in disc degeneration. Spine. 1996;21(8):863-79.
41. Illien-Jünger S, et al. AGEs induce abnormal stiffening of the human nucleus pulposus in vitro. Spine. 2013;38(17):E1040-E1047.
42. Yurube T, et al. Emerging treatments for intervertebral disc degeneration targeting cytokines, epigenetics, and ECM. JOR Spine. 2020;3(2):e1083.
43. Johnson WE, et al. Immunohistochemical study of cytokines in human intervertebral discs: implications for disc degeneration and repair. Spine. 2001;26(5):593-99.
44. Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, et al. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 2010;62(7):1974-82.
45. Risbud MV, et al. Inflammatory cytokines and matrix degrading enzymes in intervertebral disc degeneration: cause or effect? Global Spine J. 2014;4(3):145-58.
46. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O’Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 1997;350(9072):178-81.
47. Lee JM, et al. The role of VEGF and angiogenesis in disc degeneration. J Bone Joint Surg Am. 2011;93(9):847-55.
48. Chen C, et al. Targeting angiogenesis and nerve ingrowth in intervertebral disc degeneration: therapeutic implications. Bone Res. 2022;10(1):45.
49. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26(17):1873-8.
50. Griffith JF, Wang YXJ, Antonio GE, Choi KC, Yu A, Ahuja AT, et al. Modified Pfirrmann grading system for lumbar intervertebral disc degeneration. Spine. 2007;32(24):E708-E712.
51. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988;166(1):193-9.
52. Jensen TS, et al. Modic changes and disc degeneration in patients with low back pain. Eur Spine J. 2008;17(6):1029-42.
53. NASS/ASNR/ASSR. Disc nomenclature version 2.0: recommendations of the combined task forces. Spine J. 2014;14(11):2525-45.
54. Brinjikji W, Diehn FE, Jarvik JG, Carr CM, Kallmes DF, Murad MH, et al. MRI findings of disc degeneration are more prevalent in adults with low back pain than in asymptomatic controls: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2015;36(12):2394-9.
55. Belavý DL, Quittner MJ, Ridgers N, Ling Y, Connell D, Rantalainen T. Running exercise strengthens the intervertebral disc. Sci Rep. 2017;7(1):45975.
56. Belavý DL, et al. Resistance training and lumbar disc health: a systematic review of controlled trials. Eur Spine J. 2021;30(2):233-49.
57. Lugo JP, et al. Undenatured type II collagen for joint support: a review of published studies. Complement Ther Med. 2016;29:57-62.
58. Luo L, et al. The efficacy of chondroitin sulfate and glucosamine for osteoarthritis: meta-analysis. J Orthop Surg Res. 2018;13(1):170.
59. Li Y, et al. Epigenetic regulation in nucleus pulposus cells: implications for intervertebral disc degeneration. Eur Cell Mater. 2016;22:226-37.
60. Noriega DC, Ardura F, Hernández-Ramajo R, Martín-Ferrero MA, Sánchez-Lite I, Toribio B, et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation. 2017;101(8):1945-51.
61. Pettine KA, et al. Autologous bone marrow concentrate injection in patients with discogenic low back pain: a prospective trial. Pain Physician. 2015;18(1):E19-E32.
62. Sloan SR, et al. Emerging regenerative approaches for intervertebral disc repair and regeneration. Curr Rev Musculoskelet Med. 2017;10(1):14-21.
63. Wang F, et al. Gene therapy for intervertebral disc degeneration: an overview of current advances and future directions. Gene Ther. 2015;22(10):547-56.
64. Périé D, et al. Injectable biomaterials for intervertebral disc regeneration: focus on minimally invasive strategies. Biomaterials. 2021;276:121018.
65. Jamaludin A, et al. Using deep learning to detect lumbar disc degeneration and predict clinical outcomes from spinal MRI: preliminary results. Eur Spine J. 2020;29(8):1866-73.
66. Fields AJ, et al. Diet-induced obesity causes metabolic changes and degenerative remodeling in the intervertebral disc. J Orthop Res. 2015;33(5):703-11.
67. Gantenbein B, et al. Nutritional modulation of intervertebral disc health. Nutrients. 2021;13(6):1824.
68. Xu H, et al. Ketogenic diet attenuates intervertebral disc degeneration in a rat model. Spine. 2022;47(5):E184-E192.
69. Wang Z, et al. Caloric restriction and intermittent fasting: potential for prevention of intervertebral disc degeneration. Front Nutr. 2021;8:689408.
70. Li Y, et al. Nutritional interventions in the management of intervertebral disc degeneration: current perspectives. Eur J Clin Nutr. 2022;76(1):23-33.
Episode 06 – Early-Onset Scoliosis
Scheduled Premiere
Exclusive Premiere • Wednesday, October 07 at 9:00 PM (BRT)
Wednesday, October 07 at 9:00 PM (BRT)
The live countdown will be activated on the eve of the premiere.

The full videocast will premiere automatically in this player on Wednesday, 10/07 at 6:00 PM (BRT).

Also premiering on Spotify
Treatise in Debate

Official videocast derived from the treatise chapters.

Episode 06 – Early-Onset Scoliosis

Lungs and the Growing Spine: thoracic development, C-EOS classification, and growth-friendly surgical techniques